Breast Cancer

Breast Cancer

New Clinical Trial for Triple Negative Breast Cancer

Phoenix Molecular Designs is currently recruiting patients with the following criteria:

Condition:

Patients who have developed Stage 4 TNBC
Patients who have cancers that have not responded to previous therapies
18 years of age and older

Patients do not have to live in a trial location to be considered. Travel reimbursement may be available.

More information coming soon.

Trial Interest Form

I am a...

First Name(Required)

Last Name(Required)

Location(Required)

Phone(Required)

Email(Required)

Gender

Conditions

Race

Contact Preference

This field is hidden when viewing the form

Trial (Origination Page)

This field is hidden when viewing the form

UTM Source

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Campaign

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

Phone(Required)

Zip Code(Required)

What is the best way to contact you?(Required)

Comments(Required)

Please let us know what's on your mind. Have a question for us? Ask away.

This field is hidden when viewing the form

Origination Page

Trial Interest Form

Locations

Michigan Healthcare Professionals TriAtria

Acute Coronary Syndrome
Advanced Metastatic Solid Tumors
Advanced Solid Malignancies
Advanced SSTR2 Positive Neuroendocrine Tumors
Advanced/Metastic Non-Small Cell Lung Cancer
Alzheimer’s Disease
Asthma
Atopic Dermatitis
Autologous RNA Cell Therapy
Bacterial Conjunctivitis
Bladder Cancer
Breast Cancer
Calcific Aortic Valve Stenosis
Chemotherapy-Induced Neuropathic Pain
Chronic Heart Failure
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Chronic Migraines
CIDP
Dermatomyositis
Diabetes
Eczema
Endocrinology
Epilepsy
Episodic Migraines
Generalized Myasthenia Gravis
Graves
Heart Failure
Hepatic Impairment
Hypertension/High Blood Pressure
Hypothyroidism
Idiopathic Generalized Epilepsy
Idiopathic Inflammatory Myopathy (IIM)
Immune Thrombocytopenic Purpura (ITP)
Inflammation
Lung Cancer
Lupus
Metastatic Neuroendocrine
Migraine
Moderate/Severe Hepatic Impairment w/ Advanced Malignancies
Moderate/Severe Hepatic Impairment with Advanced Malignancies
Multiple Myeloma
Multiple Sclerosis
Multiple Sclerosis Relapse
Myasthenia Gravis
Neurodegenerative Disease
Non-Small Cell Lung Cancer
Nonrelapsing Secondary Progressive Multiple Sclerosis
Obesity
Obstructive Sleep Apnea
Oligometastatic Prostate Cancer (OMPC)
Parkinson's Disease
Postural Orthostatic Tachycardia Syndrome (POTS)
Primary Immune Thrombocytopenia (ITP)
Progressive Supranuclear Palsy
Prostate Cancer
Prurigo Nodularis
Psoriasis
Refractory Focal Onset Epilepsy
Refractory Multiple Myeloma (RRMM)
Relapse-Remitting Multiple Sclerosis
Relapsing Multiple Sclerosis
Rheumatoid Arthritis
Scintillate Multiple Sclerosis
Sleep Apnea
Soft Tissue Sarcoma
Solid Tumors
Squamous NSCLC
Systemic Lupus Erythematosus
Sytemic Lupus Erythematosus
Thyroid Eye Disease
Thyroid Eye Disease (TED)
Type 1 Diabetes
Warm Autoimmune Hemolytic Anemia (wAIHA)